期刊
JOURNAL OF ATTENTION DISORDERS
卷 27, 期 1, 页码 14-25出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/10870547221112948
关键词
prescription stimulants; non-medical use; intranasal use; ADHD
This study examined non-oral use of prescription stimulants, specifically intranasal use, in young adults. The results revealed that 32% of the participants reported intranasal use of prescription stimulants, with Adderall being the most commonly used drug. Most intranasal users spent less than 5 minutes tampering with the medication, and they would resort to oral consumption if unable to use it intranasally.
Objective: Few studies of prescription stimulant non-oral, non-medical use (NMU) (defined by use not as prescribed) have been conducted in adults beyond the college population. The purpose of this study was to characterize prescription stimulant non-oral use, specifically intranasal (IN) use (snorting) in young adults. Method: Amazon's MTurk platform was used to recruit participants for an online survey. Data were collected from March to April 2020. Results: Thirty-two percent (n = 157) of survey respondents (N = 975), aged 18 to 30, reported IN prescription stimulant use (average of 32.1 episodes of lifetime IN use). Adderall was the most-reported prescription stimulant used intranasally (89.2%). Most IN users (82%; n = 68) reported spending no more than 5 minutes tampering with prescription stimulants. Intranasal users said they would take the medication orally if unable to tamper or manipulate medication for IN use. Conclusion: These data help quantify a complex public health issue of ongoing IN use of prescription stimulants and suggest a potential role for manipulation-deterrent medications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据